CSW Industrials vs Orion
CSW and OEC side by side, both in chemicals and allied products. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How CSW and OEC compare
CSW Industrials is the larger company, worth 20 times as much as Orion ($4.6B against $226M).
CSW Industrials grew revenue faster over the last twelve months (30.0% versus 0.86% for Orion).
CSW Industrials keeps more of each dollar of sales as profit, with a net margin of 10.2% compared with −1.8% at Orion.
Both pay dividends: CSW Industrials yields 0.31% and Orion 1.6%.
CSW Industrials scores higher on the StockData Score (10 against 8 for Orion), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | CSW | OEC |
|---|---|---|
| Size and price | ||
| Market cap | $4.6B | $226M |
| Share price | $283.04 | $3.99 |
| Change, 1 year | 15.5% | −16.5% |
| Change, 5 years | 105% | −78.2% |
| Beta (5Y) | 1.01 | 1.06 |
| Employees | 2,700 | 1,650 |
| StockData Score | ||
| Total score | 10 (better) | 8 |
| Valuation score | 0 | 4 (better) |
| Growth score | 2 (better) | 0 |
| Performance score | 2 (better) | 0 |
| Health score | 3 (better) | 2 |
| Dividend score | 3 (better) | 2 |
| Valuation | ||
| P/E | 36.4× | – |
| P/S | 3.7× | 0.1× (better) |
| P/B | – | 0.6× |
| EV/EBITDA | 25.2× | 5.4× (better) |
| P/FCF | 26.0× | 5.2× (better) |
| PEG | 13.89 | – |
| FCF yield | 3.8% | 19.3% (better) |
| Fair value | $208.91 | $25.42 |
| Margin of safety | −35.5% | 84.3% (better) |
| Growth | ||
| Revenue growth (TTM) | 30.0% (better) | 0.86% |
| Revenue growth, 5Y average | 20.9% (better) | 9.7% |
| Net income growth (TTM) | −11.2% | – |
| EPS growth (TTM) | −8.7% | – |
| EPS growth, 5Y average | 20.4% | – |
| Profitability | ||
| Gross margin | 42.1% (better) | 18.5% |
| Operating margin | 16.9% (better) | 4.0% |
| Net margin | 10.2% (better) | −1.8% |
| FCF margin | 14.2% (better) | 2.4% |
| Return on equity | – | −8.1% |
| Return on invested capital | – | 2.7% |
| Financial health | ||
| Debt / equity | – | 2.48 |
| Net debt / EBITDA | 3.43 (better) | 4.30 |
| Current ratio | 2.35 (better) | 1.06 |
| Altman Z-score | 3.88 (better) | 1.44 |
| Piotroski F-score | 3 | 3 |
| Dividends and buybacks | ||
| Dividend yield | 0.31% | 1.6% (better) |
| Payout ratio | 14.7% | – |
| Years of dividend growth | – | 0 |
| Dividend growth, 5Y average | – | −16.7% |
| Buyback yield | 3.2% (better) | 0.35% |
| Shareholder yield | 3.5% (better) | 1.9% |
| Ownership | ||
| Held by institutions | 101% | 94.1% |
| Held by insiders | 1.4% | 4.1% |
| Insider net buying, 12 months | −$8.7M | – |
| Superinvestors holding | – | 1 |
| Short interest, % of float | 6.3% | 4.0% |
Go deeper
- CSW stock overview
- CSW income statement
- CSW valuation and score
- OEC stock overview
- OEC income statement
- OEC valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.